Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Acquired Immunodeficiency Syndrome × Alemtuzumab × 90 days × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Adenocarcinoma, Clear Cell 1

Interventions

pomalidomide 2 liposomal doxorubicin 2 plerixafor 1 abemaciclib 1 Vincristine 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Nivolumab 1 Maraviroc 1 Fluorouracil 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 Benzethonium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡